Roflumilast Attenuates Neuroinflammation and Cognitive Impairment in Intracerbroventricular-Streptozotocin Induced Rat Model of Sporadic Alzheimer’s Disease through Modulation of cAMP/BDNF Signaling Pathway

Abstract

Sporadic Alzheimer’s disease (SAD) is the most complex and multifactorial neurodegenerative disease characterized by progressive cognitive deficits and memory loss. Phosphodiesterase (PDE) inhibitors prevent the breakdown of cAMP in the brain, which is an important intracellular secondary messenger for learning and memory functions. Thus, the present study was designed to explore the therapeutic potential of PDE-4 inhibitor roflumilast (RFM) against intracerebroventricular-streptozotocin (ICV-STZ) induced SAD in rats. Subsequently, in vivo study was performed in which rats were infused intracerebroventricularly with two alternate doses of STZ (3 mg/kg bilaterally) proceeding with RFM (0.05 mg/kg orally) treatment for 15 days. Moreover, donepezil, an acetylcholinesterase inhibitor (5 mg/kg orally) was used as a standard drug. Consequently, we observed that RFM significantly improved the ICV-STZ impaired cognitive function in rats as assessed by novel object recognition and Morris Water Maze outcomes. RFM was found to remarkably mitigate the ICV-STZ triggered cholinergic deficits, neuroinflammation, oxidative stress, in rat hippocampus. Supporting these, histopathological analysis using Cresyl violet, and Congo red revealed that RFM attenuated neuronal changes, and Aβ deposition respectively in hippocampus of SAD rats. These outcomes present RFM as an efficient target for the treatment of SAD through activation of cAMP/BDNF signaling pathway.

Authors and Affiliations

Noorul Hasan, Abul Kalam Najmi, Suhel Parvez, Mohd Akhtar*

Keywords

Related Articles

Behavioral and Histological Aspects of Osteoarthritis Pain

Background and aims: Osteoarthritis (OA) is a degenerative joint disease, which is identified by cartilage degradation, subchondral bone remodeling, and inflammation of joint capsule. Each of these changes can impact o...

Intranasal Administration of Epidermal Neural Crest Stem Cells Improved Impairments in the Rat Model of Ischemic Stroke

Stem cell-based therapy has received considerable attention as a potential candidate in the domain of ischemic stroke treatment. However, employing appropriate type of stem cells and effective delivery of these cells to...

Altering TGF-β signaling pathway: An approach to halt pentylenetetrazole-induced epileptogenesis in mice

Epilepsy is illustrated by persistent predisposition of the brain to generate seizures and considered as one of the most common, chronic, neurological disorder affecting around 1% of the individuals worldwide. A growing...

The Effect of Hydro-Alcoholic Extract of Cichorium Intybus Leaf on PTZ-Induced Seizure in Male Mice

Introduction: Regarding to chronic nature of epilepsy, side effects and resistance to chemical drugs, and with the objective to access to more effective treatment procedures, herbal medicine have received remarkable int...

The Effects of Myricitrin on the Brain Edema, Neurological Scores and Blood-Brain Barrier Permeability, after Severe Traumatic Brain Injury in Male Rat: The Role of Matrix Metallopeptidase-9

Introduction: Brain trauma is one of the leading causes of death among young people worldwide today and one of the leading causes of hospitalization. Myricitrin (Myr) is a natural compound, a flavonoid glycoside, which...

Download PDF file
  • EP ID EP701741
  • DOI -
  • Views 94
  • Downloads 0

How To Cite

Noorul Hasan, Abul Kalam Najmi, Suhel Parvez, Mohd Akhtar* (2021). Roflumilast Attenuates Neuroinflammation and Cognitive Impairment in Intracerbroventricular-Streptozotocin Induced Rat Model of Sporadic Alzheimer’s Disease through Modulation of cAMP/BDNF Signaling Pathway. The 2nd Annual Meeting of International Center for Neuroscience Research, 2(1), -. https://europub.co.uk/articles/-A-701741